Donepezil-DLB Study Investigators. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: Results from a 52-week, open-label, multicenter extension study - Ikeda, M; Mori, E; Kosaka, K (Dement Geriatr Cogn Disord, 2013)
(3-4):